---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-053124"
form_type: "8-K"
ticker: "DHR"
cik: "0000313616"
company_name: "DANAHER CORP /DE/"
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:36:24.283082+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Danaher to acquire Masimo for $180/share cash, ~$9.9B enterprise value

## Summary
- All-cash deal at $180/share; total enterprise value ~$9.9B including assumed debt.
- Represents ~18x estimated 2027 EBITDA, or 15x including full annual synergies.
- Masimo to operate as standalone company within Danaher's Diagnostics segment.
- Expected to close H2 2026; subject to Masimo shareholder and regulatory approvals.
- Expects $125M annual cost synergies and >$50M revenue synergies by year 5; EPS accretive $0.15–0.20 first year.

## SEC filing metadata
- accession: 0001193125-26-053124
- form_type: 8-K
- ticker: DHR
- cik: 0000313616
- company_name: DANAHER CORP /DE/
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 8.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/0001193125-26-053124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/d110495d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-053124
- JSON: https://secwatch.observer/filing/0001193125-26-053124.json
- Plain text: https://secwatch.observer/filing/0001193125-26-053124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.